In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
The price of Acadia Pharmaceuticals Inc (NASDAQ: ACAD) closed at $21.98 in the last session, up 3.00% from day before closing price of $21.34. In other words, the price has increased by $3.00 from its previous closing price. On the day, 1.28 million shares were traded.
Ratios:
We take a closer look at ACAD’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 24.78. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.
On February 11, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $22.
Guggenheim Downgraded its Buy to Neutral on January 03, 2025, whereas the target price for the stock was revised from $23 to $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 04 ’25 when Brege Laura sold 14,446 shares for $21.78 per share. The transaction valued at 314,634 led to the insider holds 15,095 shares of the business.
LAURA BREGE bought 14,446 shares of ACAD for $314,638 on Jun 04 ’25. On May 16 ’25, another insider, Kihara James, who serves as the PRINCIPAL ACCOUNTING OFFICER of the company, sold 4,000 shares for $22.50 each. As a result, the insider received 90,000 and left with 20,395 shares of the company.
Valuation Measures:
As of this moment, Acadia’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.00, and their Forward P/E ratio for the next fiscal year is 25.73. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.40. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.69 while its Price-to-Book (P/B) ratio in mrq is 4.80.
Stock Price History:
Over the past 52 weeks, ACAD has reached a high of $25.23, while it has fallen to a 52-week low of $13.40. The 50-Day Moving Average of the stock is 26.44%, while the 200-Day Moving Average is calculated to be 29.09%.
Shares Statistics:
A total of 167.12M shares are outstanding, with a floating share count of 166.00M. Insiders hold about 0.81% of the company’s shares, while institutions hold 103.78% stake in the company.
